KC
CELUW icon

Kepos Capital’s Celularity Inc CELUW Stock Holding History

Kepos Capital’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-450,000
Closed -$1.3M – 428
2020
Q4 		$1.3M Hold
450,000
– – 0.11% 194
2020
Q3 		$720K Sell
450,000
-74,200
-14% -$112K 0.08% 163
2020
Q2 		$577K Hold
524,200
– – 0.07% 133
2020
Q1 		$288K Sell
524,200
-800
-0.2% -$685 0.06% 123
2019
Q4 		$420K Buy
525,000
+345,000
+192% +$244K 0.04% 247
2019
Q3 		$105K Buy
+180,000
New +$103K 0.01% 299

Other funds holding CELUW

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
EC
EJF Capital Arlington, Virginia $142M AUM 23.3% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Kepos Capital's CELUW Position: Q1 2021 in Review

Kepos Capital sold out of Celularity Inc (CELUW) in Q1 2021, closing a stake of 450,000 shares — an estimated $1.3M sold.

Kepos Capital first reported a position in CELUW in Q3 2019 and held it in 6 quarters. The position peaked at $1.3M in Q4 2020. 23 funds tracked by Wall St. Rank hold CELUW as of Q1 2021.

  • Kepos Capital reported no remaining Celularity Inc position as of Q1 2021 after selling out during the quarter.
  • Kepos Capital sold 450,000 Celularity Inc shares in Q1 2021, an estimated $1.3M.
  • Kepos Capital first reported a position in Celularity Inc in Q3 2019 and held it in 6 quarters.
  • Kepos Capital's Celularity Inc position peaked at $1.3M in Q4 2020.
  • 23 funds tracked by Wall St. Rank held Celularity Inc as of Q1 2021.

Based on Kepos Capital's 13F filing for Q1 2021, filed 13 May 2021.